Impact of 1p/19q Codeletion and Histology on Outcomes of Anaplastic Gliomas Treated With Radiation Therapy and Temozolomide-Reference-Cited by-同舟云学术

Impact of 1p/19q Codeletion and Histology on Outcomes of Anaplastic Gliomas Treated With Radiation Therapy and Temozolomide

Published:2015-02 Issue:2 Volume:91 Page:268-276
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Speirs Christina K.,Simpson Joseph R.^ORCID,Robinson Clifford G.^ORCID,DeWees Todd A.,Tran David D.,Linette Gerry,Chicoine Michael R.,Dacey Ralph G.,Rich Keith M.,Dowling Joshua L.,Leuthardt Eric C.,Zipfel Gregory J.,Kim Albert H.,Huang Jiayi^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference25 articles.

1. 1p/19q codeletion and IDH1/2 mutation identified a subtype of anaplastic oligoastrocytomas with prognosis as favorable as anaplastic oligodendrogliomas;Jiang;Neuro Oncol,2013

2. Current strategies in treatment of oligodendroglioma: Evolution of molecular signatures of response;Jaeckle;J Clin Oncol,2006

3. Molecular subtypes of anaplastic oligodendroglioma: Implications for patient management at diagnosis;Ino;Clin Cancer Res,2001

4. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402;Cairncross;J Clin Oncol,2006

5. Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N6-methyladenosine-related microRNAs risk model trumps the isocitrate dehydrogenase mutation status as a predictive biomarker for the prognosis and immunotherapy in lower grade gliomas;Exploration of Targeted Anti-tumor Therapy;2022-09-30

2. DLL3 expression and methylation are associated with lower-grade glioma immune microenvironment and prognosis;Genomics;2022-03

3. Chaperonin‐containing tailless complex polypeptide 1 subunit 6A correlates with increased World Health Organization grade, less isocitrate dehydrogenase mutation, and deteriorative survival of astrocytoma patients;Journal of Clinical Laboratory Analysis;2021-07-27

4. Radiomics in neuro-oncology: Basics, workflow, and applications;Methods;2021-04

5. Challenges and Perspectives of Standard Therapy and Drug Development in High-Grade Gliomas;Molecules;2021-02-22